Hematology/Oncology Education and CME

Select a Specialty

Lymphoma Central

Lymphoma Central is here, your hub for treatment breakthroughs, clinical trial news and expert analysis….

go to activity»
Expert Update: What's New in Essential Thrombocythemia
CME

Expert Update: What's New in Essential Thrombocythemia

This activity is supported by an educational grant from Incyte Corporation.

Expiration Date: 8/22/2018
Credit Type(s): CME | Credit: 0.5

Appropriate early diagnosis and initiation of therapy is essential in the management of myeloproliferative neoplasms (MPNs) to enhance clinical outcomes and patient…

go to activity»
Castration-resistant prostate cancer
CME

Bridging the Gap from Knowledge to Practice in CRPC

This activity is supported by educational funding provided by AbbVie Inc.; Astellas Scientific and Medical Affairs, Inc. and Medivation; and Sanofi US.

Expiration Date: 11/17/2017
Credit Type(s): CME | Credit: 1

The selection of therapy for patients with castration-resistant prostate cancer (CRPC) remains challenging. Review answers to some of the most important questions posed…

go to activity»
HemOnc IMS Sarcoma

Read what three clinicians have to say about the current state of sarcoma treatment options….

go to activity»
j331
CME

What's Hot in Melanoma? Highlights from the HemONC Today Melanoma and Cutaneous Malignancies 2017 Meeting

This activity is supported by an educational grant from Merck & Co, Inc.

Expiration Date: 4/10/2018
Credit Type(s): CME | Credit: 0.5

The development and integration of targeted therapies, as well as immunotherapies, into clinical strategies for the management of advanced melanoma has revolutionized…

go to activity»
Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices
CME

Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

This activity is supported by an educational grant from Merck & Co, Inc.

Expiration Date: 4/2/2018
Credit Type(s): CME | Credit: 1

Advances in immunology and the advent of immune checkpoint blockade inhibition for advanced bladder cancer are poised to cause a paradigm shift in the near future…

go to activity»
Meeting Rewind Video Highlights from HemOnc Today Melanoma

Select video presentations from HemOnc Today Melanoma include topics such as melanoma pathways and targeted therapeutics….

go to activity»
Multiple Myeloma Patient Management Embracing New Advancements Overcoming New Challenges
CME

Multiple Myeloma Patient Management: Embracing New Advancements, Overcoming New Challenges

Support for this activity has been provided through educational grants from Amgen; Celgene Corporation; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Oncology.

Expiration Date: 6/8/2018
Credit Type(s): CME | Credit: 1

The multiple myeloma clinical landscape has evolved significantly, with not only 10 new drugs but also new staging standards (ie, the R-ISS), imaging techniques, and…

go to activity»
Polycythemia Vera: Aligning Real World Practices With Current Best Practices
CME

Polycythemia Vera: Aligning Real World Practices With Current Best Practices

This activity is supported by an independent educational grant from Incyte Corporation.

Expiration Date: 11/12/2017
Credit Type(s): CME | Credit: 1

Ruben A. Mesa, MD, provides practical insights into treating polycythemia vera in this video series. In addition to discussing risk stratification, Dr. Mesa uses case…

go to activity»
Immune Checkpoint Inhibitors for Advanced Melanoma: Clinical Updates and Multidisciplinary Strategies
CME

Immune Checkpoint Inhibitors for Advanced Melanoma: Clinical Updates and Multidisciplinary Strategies

This activity is supported by an educational grant from Bristol-Myers Squibb.

Expiration Date: 4/27/2018
Credit Type(s): CME | Credit: 1

Incidence rates of melanoma in the United States continue to rise, with an estimated 87,110 new cases being diagnosed in 2017. The early detection of melanoma is…

go to activity»
Multiple Myeloma Central

Read the latest on emerging therapies, review important clinical trials and explore future treatment and management….

go to activity»
The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers
CMECNE

The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers

This activity is supported by an educational grant from Bristol-Myers Squibb.

Expiration Date: 3/20/2018
Credit Type(s): CNE / CME | Credit: 1

The incorporation of immunotherapies, especially the immune checkpoint inhibitors, into treatment regimens for patients with cancer, have significantly improved clinical…

go to activity»